Skip to main content

Table 8 Trial management

From: Protocol for the combined immunosuppression & radiotherapy in thyroid eye disease (CIRTED) trial: A multi-centre, double-masked, factorial randomised controlled trial

Core trial management committee
Richard Lee Chief Investigator (Ophthalmology), University of Bristol and Bristol Eye Hospital, UK
Colin Dayan Chief Investigator (Endocrinology), University of Bristol and Bristol Royal Infirmary, UK
Jimmy Uddin Principal investigator (Ophthalmology), Moorfields Eye Hospital. London, UK
Rathie Rajendram Co-investigator (Ophthalmology), Moorfields Eye Hospital, London, UK
Catey Bunce Medical statistician, Moorfields Eye Hospital, London, UK
Trial Steering Committee
Maarten P Mourits Professor of Ophthalmology, Academic Medical Centre, Amsterdam, NL
John Lazarus Professor of Endocrinology, University of Wales, Cardiff, UK
John Sparrow Consultant Ophthalmologist, Bristol Eye Hospital, UK
Data Monitoring Committee
John Forrester Professor of Ophthalmology, University of Aberdeen and Aberdeen Royal Infirmary, UK
Gillian Adams Consultant Ophthalmologist, Moorfields Eye Hospital, London, UK
Roberto Melotti Senior statistician, North Bristol NHS Trust, Bristol, UK